Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update

Published Date: 31st October 2023

Publication Authors: Nune A

Dear Editor
Polymyalgia rheumatica (PMR) has been reported as an adverse event following immunisation (AEFI) with COVID-19 vaccines [1, 2]. In April 2022, we published in Reumatologia a narrative review, stating that reports of PMR following COVID-19 vaccination were rare AEFI. Among these, atypical presentation (so-called “PMR-like sytndromes”) were not uncommon. A shared understanding of the relationship between COVID-19 vaccination and PMR/PMR-like syndromes was to follow [3]...

 

Manzo, C.; Nune, A. et al. (2023). Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update. Reumatologia. 61(5), pp.408-409. [Online]. Available at: https://doi.org/10.5114/reum/172508 [Accessed 26 February 2024].

 

« Back